{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:56:56Z","timestamp":1770749816554,"version":"3.50.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801592"],"award-info":[{"award-number":["81801592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671589, 81871272,"],"award-info":[{"award-number":["81671589, 81871272,"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Sailing Program","award":["18YF1414100"],"award-info":[{"award-number":["18YF1414100"]}]},{"name":"Shanghai Jiao Tong University Interdisciplinary Research Project","award":["YG2016QN60"],"award-info":[{"award-number":["YG2016QN60"]}]},{"name":"Excellent Youth B Project","award":["GCQN-2017-B05"],"award-info":[{"award-number":["GCQN-2017-B05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10067-019-04670-7","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:53:15Z","timestamp":1562676795000},"page":"3161-3168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China"],"prefix":"10.1007","volume":"38","author":[{"given":"Zhuochao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2823-4349","authenticated-orcid":false,"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"issue":"9751","key":"4670_CR1","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","volume":"376","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 376(9751):1498\u20131509","journal-title":"Lancet"},{"issue":"1","key":"4670_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12016-016-8571-6","volume":"53","author":"A Ruffatti","year":"2017","unstructured":"Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U et al (2017) Additional treatments for high-risk obstetric antiphospholipid syndrome: a comprehensive review. Clin Rev Allergy Immunol 53(1):28\u201339","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"4670_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346(10):752\u2013763","journal-title":"N Engl J Med"},{"issue":"8","key":"4670_CR4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","volume":"10","author":"RS Rai","year":"1995","unstructured":"Rai RS, Regan L, Clifford K, Pickering W, Dave M, Mackie I et al (1995) Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 10(8):2001\u20132005","journal-title":"Hum Reprod"},{"issue":"11","key":"4670_CR5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1586\/1744666X.2014.968129","volume":"10","author":"CB Chighizola","year":"2014","unstructured":"Chighizola CB, Gerosa M, Trespidi L, Di Giacomo A, Rossi F, Acaia B et al (2014) Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome. Expert Rev Clin Immunol 10(11):1505\u20131517","journal-title":"Expert Rev Clin Immunol"},{"key":"4670_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ram\u00f3n E et al (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74:1011\u20131018","journal-title":"Ann Rheum Dis"},{"key":"4670_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","volume":"14","author":"J Alijotas-Reig","year":"2015","unstructured":"Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT et al (2015) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun Rev 14:387\u2013395","journal-title":"Autoimmun Rev"},{"key":"4670_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11926-013-0403-6","volume":"16","author":"GR de Jes\u00fas","year":"2014","unstructured":"de Jes\u00fas GR, Rodrigues G, de Jes\u00fas NR, Levy R (2014) Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? Curr Rheumatol Rep 16:403","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"4670_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2018.01.027","volume":"17","author":"C Belizna","year":"2018","unstructured":"Belizna C, Stojanovich L, Cohen-Tervaert JW et al (2018) Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: are they different entities? Autoimmun Rev 17(8):739\u2013745","journal-title":"Autoimmun Rev"},{"issue":"9","key":"4670_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","volume":"17","author":"R Paule","year":"2018","unstructured":"Paule R, Morel N, Le Guern V et al (2018) Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients. Autoimmun Rev 17(9):866\u2013872","journal-title":"Autoimmun Rev"},{"key":"4670_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/OGX.0b013e31828aca19","volume":"68","author":"J Alijotas-Reig","year":"2013","unstructured":"Alijotas-Reig J, Garrido-Gimenez C (2013) Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstet Gynecol Surv 68:445\u2013466","journal-title":"Obstet Gynecol Surv"},{"key":"4670_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","volume":"13","author":"D Erkan","year":"2014","unstructured":"Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A et al (2014) 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13:685\u2013696","journal-title":"Autoimmun Rev"},{"key":"4670_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fimmu.2018.00864","volume":"9","author":"M Fredi","year":"2018","unstructured":"Fredi M, Andreoli L, Aggogeri E et al (2018) Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: results from a multicenter study of 283 pregnancies. Front Immunol 9:864","journal-title":"Front Immunol"},{"issue":"4","key":"4670_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jth.13257","volume":"14","author":"T Marchetti","year":"2016","unstructured":"Marchetti T, de Moerloose P, Gris JC (2016) Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study. J Thromb Haemost 14(4):675\u2013684","journal-title":"J Thromb Haemost"},{"key":"4670_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10067-017-3549-1","volume":"36","author":"H Shi","year":"2017","unstructured":"Shi H, Teng JL, Sun Y, Wu XY, Hu QY, Liu HL et al (2017) Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort. Clin Rheumatol 36:1\u201310","journal-title":"Clin Rheumatol"},{"key":"4670_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309\u20131311","journal-title":"Arthritis Rheum"},{"key":"4670_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"4670_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"4670_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534","journal-title":"Lupus"},{"key":"4670_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1055\/s-0036-1592336","volume":"42","author":"K Schreiber","year":"2016","unstructured":"Schreiber K, Hunt BJ (2016) Pregnancy and antiphospholipid syndrome. Semin Thromb Hemost 42:780\u2013788","journal-title":"Semin Thromb Hemost"},{"key":"4670_CR21","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1177\/0961203317703493","volume":"26","author":"N Fernandez Mosteirin","year":"2017","unstructured":"Fernandez Mosteirin N, Saez Comet L, Salvador Osuna C, Calvo Villas JM, Velilla Marco J (2017) Independent validation of the adjusted GAPSS: role of thrombotic risk assessment in the real-life setting. Lupus 26:1328\u20131332","journal-title":"Lupus"},{"issue":"10","key":"4670_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G et al (2009) Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 7(10):1737\u20131740","journal-title":"J Thromb Haemost"},{"issue":"1","key":"4670_CR23","doi-asserted-by":"publisher","first-page":"e000131","DOI":"10.1136\/lupus-2015-000131","volume":"3","author":"CM Yelnik","year":"2016","unstructured":"Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM et al (2016) Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 3(1):e000131","journal-title":"Lupus Sci Med"},{"issue":"7","key":"4670_CR24","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/art.34402","volume":"64","author":"MD Lockshin","year":"2012","unstructured":"Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, al w (2012) Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anti-cardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 64(7):2311\u20132318","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4670_CR25","doi-asserted-by":"publisher","first-page":"525.e1","DOI":"10.1016\/j.ajog.2017.01.026","volume":"216","author":"G Saccone","year":"2017","unstructured":"Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G et al (2017) Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol 216(5):525.e1\u2013525.e12","journal-title":"Am J Obstet Gynecol"},{"key":"4670_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1515\/cclm-2017-0502","volume":"56","author":"H Shi","year":"2018","unstructured":"Shi H, Zheng H, Yin YF, Hu QY, Teng JL, Sun Y et al (2018) Antiphosphatidylserine\/prothrombin antibodies (aPS\/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome. Clin Chem Lab Med 56:614\u2013624","journal-title":"Clin Chem Lab Med"},{"key":"4670_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10067-016-3498-0","volume":"36","author":"L Zhu","year":"2017","unstructured":"Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R et al (2017) Diagnostic value of antibodies to phosphatidylserine\/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol 36:401\u2013406","journal-title":"Clin Rheumatol"},{"key":"4670_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10067-016-3510-8","volume":"36","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wu Z, Li J, Wen X, Li L, Zhang W et al (2017) Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome. Clin Rheumatol 36:407\u2013412","journal-title":"Clin Rheumatol"},{"key":"4670_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00296-016-3594-0","volume":"37","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wu Z, Li J, Li P, Chen S, Wen X et al (2017) Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events. Rheumatol Int 37:579\u2013584","journal-title":"Rheumatol Int"},{"key":"4670_CR30","doi-asserted-by":"publisher","first-page":"23839","DOI":"10.1038\/srep23839","volume":"6","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wu Z, Chen S, Li J, Wen X, Li L et al (2016) Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome. Sci Rep 6:23839","journal-title":"Sci Rep"},{"issue":"4","key":"4670_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.autrev.2018.12.006","volume":"18","author":"J Alijotas-Reig","year":"2019","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R et al (2019) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases. Autoimmun Rev 18(4):406\u2013414","journal-title":"Autoimmun Rev"},{"key":"4670_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/etm.2012.743","volume":"5","author":"J Xiao","year":"2013","unstructured":"Xiao J, Xiong J, Zhu F, He L (2013) Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome. Exp Ther Med 5:287\u2013291","journal-title":"Exp Ther Med"},{"key":"4670_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Lazzaroni MG, Kuzenko A, Alijotas-Reig J, Ruffatti A, Levy P et al (2015) The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study. Autoimmun Rev 14:498\u2013502","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4670_CR34","first-page":"639","volume":"118","author":"A Ruffatti","year":"2018","unstructured":"Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO et al (2018) Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study. Thromb Haemost 118(4):639\u2013646","journal-title":"Thromb Haemost"},{"key":"4670_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.autrev.2015.11.009","volume":"15","author":"S Tenti","year":"2016","unstructured":"Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A (2016) Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature. Autoimmun Rev 15:226\u2013235","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4670_CR36","first-page":"727","volume":"112","author":"A Ruffatti","year":"2014","unstructured":"Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A et al (2014) Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost 112(4):727\u2013735","journal-title":"Thromb Haemost"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04670-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:27:43Z","timestamp":1594164463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04670-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4670"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04670-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}